Showing 1,021 - 1,040 results of 1,107 for search '"Austria"', query time: 0.07s Refine Results
  1. 1021
  2. 1022

    Study protocol of a randomised controlled trial on SISU, a software agent providing a brief self-help intervention for adults with low psychological well-being by Harald Baumeister, Ann-Marie Küchler, David Ebert, Natalie Bauereiss, Eileen Bendig, Benjamin Erb, Lena Weger, Echo Meißner

    Published 2021-02-01
    “…The aim of this trial is to evaluate the clinical effectiveness and acceptance of the brief software agent-based IMI SISU in comparison with a waitlist control group.Methods and analysis Within a two-group randomised controlled trial, a total of 120 adult participants living with low well-being (Well-being Scale/WHO-5) will be recruited in Germany, Austria and Switzerland. SISU is based on therapeutic writing and acceptance and commitment therapy-based principles. …”
    Get full text
    Article
  3. 1023
  4. 1024

    Effectiveness of treatment for different stages of diabetic retinopathy in type 2 diabetes by A.V. Serdiuk, S.Yu. Mogilevskyy, S.V. Zyablitzev, O.Yu. Denisiuk

    Published 2024-11-01
    “…The analysis of the results was carried out in the EZR v. 1.54 package (Austria), the classification of models — in the Statistica Neural Networks v. 4.0C (StatSoft Inc.). …”
    Get full text
    Article
  5. 1025
  6. 1026
  7. 1027
  8. 1028
  9. 1029

    Molecular Patterns of MEFV Gene Mutations in Egyptian Patients with Familial Mediterranean Fever: A Retrospective Cohort Study by Amal R. Mansour, Ayman El-Shayeb, Nihal El Habachi, Mohamad A. Khodair, Doaa Elwazzan, Nermeen Abdeen, Marwa Said, Riham Ebaid, Noha ElShahawy, Amr Seif, Nadia Zaki

    Published 2019-01-01
    “…FMF Strip Assay (Vienna Lab Diagnostics, Vienna, Austria) was used. This test is based on reverse hybridization of biotinylated PCR products on immobilized oligonucleotides for mutations and controls in a parallel array of allele-specific oligonucleotides. …”
    Get full text
    Article
  10. 1030
  11. 1031

    The implementation and side effect management of immune checkpoint inhibitors in gynecologic oncology: a JAGO/NOGGO survey by Maximilian Riedel, Helene Herrmann, Thomas Bartl, Anna-Maria Rossner, Anna Tatzber, Chiara Flethe, Dario Zocholl, Barbara Schmalfeldt, Jalid Sehouli, Klaus Pietzner

    Published 2025-01-01
    “…The aim of this survey was to provide a real-world overview of the experiences and the current state of irAE management of ICIs in Germany, Switzerland, and Austria. Methods We designed a questionnaire consisting of 34 items focused on physicans’ clinical experiences with ICIs and their management of irAEs. …”
    Get full text
    Article
  12. 1032

    Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial by Djawid Hashemi, Ludwig Dettmann, Tobias D. Trippel, Volker Holzendorf, Johannes Petutschnigg, Rolf Wachter, Gerd Hasenfuß, Burkert Pieske, Antonia Zapf, Frank Edelmann

    Published 2020-06-01
    “…Methods and results The aldosterone receptor blockade in diastolic HF trial is a multicentre, prospective, randomized, double‐blind, placebo‐controlled trial conducted between March 2007 and April 2011 at 10 sites in Germany and Austria that included 422 ambulatory patients [mean age: 67 years (standard deviation: 8); 52% women]. …”
    Get full text
    Article
  13. 1033
  14. 1034

    “Beyond the Finish Line” the Epidemiology of Injury and Illness in Professional Cycling: Insights from a Year-Long Prospective Study by Thomas Fallon, Rory Nolan, John Peters, Neil Heron

    Published 2025-01-01
    “…(V.4.3.2, R Foundation for Statistical Computing, Vienna, Austria). Ethical approval was obtained from Queens University Belfast, number MHLS 23_175. …”
    Get full text
    Article
  15. 1035
  16. 1036
  17. 1037
  18. 1038

    Blood and Iron: The Rise and Fall of the German Empire 1871 – 1918 by Arzu Melek Ozgumus

    Published 2024-12-01
    “…Although the German Confederation created at that time was led by Austria, the balance of power began to shift with the rise of Otto von Bismarck in the politics. …”
    Get full text
    Article
  19. 1039
  20. 1040